Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammation | 3 | 2017 | 758 | 0.590 |
Why?
|
| Interleukin-15 | 2 | 2017 | 13 | 0.540 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 139 | 0.480 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 290 | 0.480 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 148 | 0.470 |
Why?
|
| Penile Neoplasms | 3 | 2021 | 12 | 0.430 |
Why?
|
| Cell Movement | 1 | 2017 | 655 | 0.390 |
Why?
|
| Prostatic Neoplasms | 4 | 2017 | 1092 | 0.390 |
Why?
|
| Cystitis | 2 | 2008 | 7 | 0.350 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 376 | 0.320 |
Why?
|
| Receptors, Nicotinic | 2 | 2008 | 114 | 0.320 |
Why?
|
| Dermis | 1 | 2009 | 9 | 0.320 |
Why?
|
| Epithelium | 1 | 2009 | 78 | 0.310 |
Why?
|
| Urinary Bladder | 2 | 2009 | 30 | 0.290 |
Why?
|
| Wound Healing | 1 | 2009 | 88 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 216 | 0.280 |
Why?
|
| Estradiol | 1 | 2007 | 268 | 0.240 |
Why?
|
| Cervix Uteri | 2 | 2023 | 48 | 0.230 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1070 | 0.190 |
Why?
|
| Mice | 8 | 2020 | 6644 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 1869 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1019 | 0.160 |
Why?
|
| Piperidones | 1 | 2019 | 10 | 0.160 |
Why?
|
| Chalcones | 1 | 2019 | 17 | 0.150 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2018 | 12 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2017 | 158 | 0.150 |
Why?
|
| Neoplasm Seeding | 1 | 2018 | 5 | 0.150 |
Why?
|
| Vitreous Body | 1 | 2018 | 10 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2020 | 144 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 16 | 0.140 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 11 | 0.140 |
Why?
|
| Retinoblastoma | 1 | 2018 | 16 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 186 | 0.140 |
Why?
|
| Metabolomics | 1 | 2018 | 95 | 0.140 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 144 | 0.140 |
Why?
|
| Cyclophosphamide | 2 | 2008 | 59 | 0.140 |
Why?
|
| Papillomaviridae | 1 | 2018 | 142 | 0.130 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 44 | 0.130 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2017 | 19 | 0.130 |
Why?
|
| Animals | 8 | 2020 | 16992 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 147 | 0.120 |
Why?
|
| Prostate | 1 | 2017 | 155 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 191 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 2676 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 356 | 0.110 |
Why?
|
| Mouth Diseases | 1 | 2014 | 5 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 367 | 0.100 |
Why?
|
| Alphapapillomavirus | 1 | 2014 | 31 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2010 | 26 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2018 | 2157 | 0.090 |
Why?
|
| Humans | 13 | 2023 | 43102 | 0.090 |
Why?
|
| Methionine | 1 | 2011 | 27 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 968 | 0.080 |
Why?
|
| Male | 8 | 2021 | 23409 | 0.080 |
Why?
|
| Granulation Tissue | 1 | 2009 | 1 | 0.080 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2009 | 3 | 0.080 |
Why?
|
| Integrases | 1 | 2009 | 28 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 116 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 95 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 165 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2009 | 114 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 200 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 79 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 256 | 0.070 |
Why?
|
| Actins | 1 | 2009 | 164 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 131 | 0.070 |
Why?
|
| Disease Progression | 1 | 2011 | 667 | 0.070 |
Why?
|
| Puerto Rico | 3 | 2023 | 1413 | 0.070 |
Why?
|
| Neoplasms | 1 | 2019 | 1377 | 0.070 |
Why?
|
| Protamines | 1 | 2008 | 21 | 0.070 |
Why?
|
| Mecamylamine | 1 | 2007 | 21 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 21 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1596 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 154 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 934 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 561 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2009 | 1035 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 291 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 383 | 0.060 |
Why?
|
| Middle Aged | 6 | 2021 | 12222 | 0.060 |
Why?
|
| Lactobacillus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 861 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1285 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 203 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 1612 | 0.040 |
Why?
|
| Female | 4 | 2023 | 24698 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 11 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 101 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 70 | 0.040 |
Why?
|
| Bacteria | 1 | 2023 | 293 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 31 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 80 | 0.040 |
Why?
|
| ROC Curve | 2 | 2011 | 159 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 374 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 98 | 0.040 |
Why?
|
| Eye Enucleation | 1 | 2018 | 3 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 327 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 39 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 506 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 8214 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 152 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 1772 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 378 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 508 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 13872 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2017 | 9 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 16 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 411 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 159 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 455 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 458 | 0.030 |
Why?
|
| Carcinogens | 1 | 2017 | 126 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 299 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 1410 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 883 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 277 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1177 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 358 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 198 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 665 | 0.030 |
Why?
|
| Risk Factors | 2 | 2014 | 3994 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2853 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 37 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 56 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 249 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2014 | 174 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2544 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 800 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 152 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 20 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2014 | 326 | 0.020 |
Why?
|
| Genes, myc | 1 | 2010 | 31 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 23 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2010 | 37 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1154 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 55 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 237 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 78 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 518 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 95 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 169 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1009 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2008 | 70 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1234 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 526 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 155 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 611 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 1024 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 735 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3156 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5080 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6081 | 0.010 |
Why?
|
| United States | 1 | 2012 | 5205 | 0.010 |
Why?
|
| HIV Infections | 1 | 2014 | 2586 | 0.010 |
Why?
|
Martinez-Ferrer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_